Seattle Genetics Reports Second Quarter 2016 Financial Results

Go back to Seattle Genetics Reports Second Quarter 2016 Financial Results

Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold

July 27, 2016 7:22 AM EDT

Cantor Fitzgerald downgraded Seattle Genetics (NASDAQ: SGEN) from Buy to Hold with a price target of $43 (unchanged).

For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.

Shares of Seattle Genetics closed at $43.77 yesterday.

... More